BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34806683)

  • 21. [Pelvic organ prolapse during pregnancy: treatment with vaginal pessary. A report of two cases].
    Arango-Buitrago V; Restrepo-Moreno M; Echavarría-Restrepo LG; Gómez-Londoño M
    Ginecol Obstet Mex; 2016 Sep; 84(9):601-6. PubMed ID: 29424981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of time interval of vaginal ring pessary replacement for pelvic organ prolapse on complications and patient satisfaction: A randomised controlled trial.
    Tam MS; Lee VYT; Yu ELM; Wan RSF; Tang JSM; He JMY; Lui LKY; Chiu KP; Cheung RYK; Lee KW
    Maturitas; 2019 Oct; 128():29-35. PubMed ID: 31561819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we define excess vaginal space? - Genital hiatus size and prolapse severity are correlated with cube pessary size.
    Nemeth Z; Farkas N; Farkas B
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():61-64. PubMed ID: 32791394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient Satisfaction and Symptoms Improvement in Women Using a Vginal Pessary for The Treatment of Pelvic Organ Prolapse.
    Radnia N; Hajhashemi M; Eftekhar T; Deldar M; Mohajeri T; Sohbati S; Ghanbari Z
    J Med Life; 2019; 12(3):271-275. PubMed ID: 31666830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
    Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
    Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pessary evaluation for genital prolapse treatment: From acceptance to successful fitting.
    Vasconcelos CTM; Gomes MLS; Geoffrion R; Saboia DM; Bezerra KC; Vasconcelos Neto JA
    Neurourol Urodyn; 2020 Nov; 39(8):2344-2352. PubMed ID: 32846016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users.
    Mendes LC; Bezerra LRPS; Bilhar APM; Neto JAV; Vasconcelos CTM; Saboia DM; Karbage SAL
    Int Urogynecol J; 2021 Apr; 32(4):1023-1029. PubMed ID: 33048180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed vesicovaginal fistula after ring pessary usage.
    Penrose KJ; Ma Yin J; Tsokos N
    Int Urogynecol J; 2014 Feb; 25(2):291-3. PubMed ID: 23801483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse.
    Lone F; Thakar R; Sultan AH; Karamalis G
    Int J Gynaecol Obstet; 2011 Jul; 114(1):56-9. PubMed ID: 21575953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with long-term pessary use in women with symptomatic pelvic organ prolapse.
    Mao M; Xu T; Kang J; Zhang Y; Ai F; Zhou Y; Zhu L
    Climacteric; 2019 Oct; 22(5):478-482. PubMed ID: 30897024
    [No Abstract]   [Full Text] [Related]  

  • 31. Concomitant vesicovaginal fistula and rectovaginal fistula in a patient with a neglected pessary placed for pelvic organ prolapse.
    Laurence J; Nghiem MA; Fernandez H; Luton D; Pelhuche A; Florin M; Deffieux X; Capmas P
    Prog Urol; 2022 Dec; 32(17):1543-1545. PubMed ID: 36041957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial.
    Cheung RY; Lee JH; Lee LL; Chung TK; Chan SS
    Obstet Gynecol; 2016 Jul; 128(1):73-80. PubMed ID: 27275798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The history and usage of the vaginal pessary: a review.
    Oliver R; Thakar R; Sultan AH
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):125-30. PubMed ID: 21255901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of incarcerated vaginal pessaries.
    Poma PA
    J Am Geriatr Soc; 1981 Jul; 29(7):325-7. PubMed ID: 7240622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
    Manonai J; Sarit-Apirak S; Udomsubpayakul U
    Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.
    Ramsay S; Tu le M; Tannenbaum C
    Int Urogynecol J; 2016 Aug; 27(8):1201-7. PubMed ID: 26872647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal Pessaries for Pelvic Organ Prolapse and Their Impact on Sexual Function.
    Rantell A
    Sex Med Rev; 2019 Oct; 7(4):597-603. PubMed ID: 31378507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Pessary Care: A Modified Delphi Consensus Study.
    Hooper GL; Atnip S; O'Dell K
    J Midwifery Womens Health; 2017 Jul; 62(4):452-462. PubMed ID: 28727233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which factors should be considered in choosing pessary type and size for pelvic organ prolapse patients in a fitting trial?
    Ding J; Song XC; Deng M; Zhu L
    Int Urogynecol J; 2016 Dec; 27(12):1867-1871. PubMed ID: 27260324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of intravaginal microbiota and inflammation after self-replacement ring pessary therapy compared to continuous ring pessary usage for pelvic organ prolapse.
    Yoshimura K; Morotomi N; Fukuda K; Kubo T; Taniguchi H
    J Obstet Gynaecol Res; 2020 Jun; 46(6):931-938. PubMed ID: 32189434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.